Header Logo

Connection

Johanna Seddon to Melanoma

Back to Details
This is a "connection" page, showing publications Johanna Seddon has written about Melanoma.
Johanna Seddon
Connection Strength
1.715
Melanoma
  1. Young TA, Seddon JM. Choroidal and cutaneous melanoma: distinctly different cousins. Ophthalmic Epidemiol. 2005 Aug; 12(4):221-2.
    View in: PubMed
    Score: 0.191
  2. Gragoudas ES, Egan KM, Saornil MA, Walsh SM, Albert DM, Seddon JM. The time course of irradiation changes in proton beam-treated uveal melanomas. Ophthalmology. 1993 Oct; 100(10):1555-9; discussion 1560.
    View in: PubMed
    Score: 0.084
  3. Seddon J, Gragoudas E, Egan K, Polivogianis L, Finn S, Albert D. Standardized data collection and coding in eye disease epidemiology: the Uveal Melanoma Data System. Ophthalmic Surg. 1991 Mar; 22(3):127-36.
    View in: PubMed
    Score: 0.070
  4. Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol. 1990 Sep; 108(9):1274-80.
    View in: PubMed
    Score: 0.068
  5. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology. 1990 Jun; 97(6):769-77.
    View in: PubMed
    Score: 0.067
  6. Smith EV, Kolodny NH, Gragoudas ES, Egan KM, Finn S, D'Amico DJ, Seddon JM. An NMR blood test for uveal melanoma? Invest Ophthalmol Vis Sci. 1990 May; 31(5):993-7.
    View in: PubMed
    Score: 0.066
  7. Seddon JM, Polivogianis L, Hsieh CC, Albert DM, Gamel JW, Gragoudas ES. Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch Ophthalmol. 1987 Jun; 105(6):801-6.
    View in: PubMed
    Score: 0.054
  8. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Munzenrider JE, Austin-Seymour M, Goitein M, Verhey L, Urie M, Koehler A. Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology. 1987 Apr; 94(4):354-61.
    View in: PubMed
    Score: 0.054
  9. Seddon JM, Gragoudas ES, Polivogianis L, Hsieh CC, Egan KM, Goitein M, Verhey L, Munzenrider J, Austin-Seymour M, Urie M, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology. 1986 May; 93(5):666-74.
    View in: PubMed
    Score: 0.050
  10. Seddon JM, Polivogianis L, Gragoudas ES, Hsieh CC, Egan KM. Enucleation vs cobalt 60 irradiation of melanomas. Arch Ophthalmol. 1986 Feb; 104(2):175-6.
    View in: PubMed
    Score: 0.050
  11. Seddon JM, Gragoudas E, Albert D, Hsieh CC, Polivogianis L, Egan K. Echographic and histologic tumor height measurements in uveal melanoma. Am J Ophthalmol. 1986 Jan 15; 101(1):126-8.
    View in: PubMed
    Score: 0.049
  12. Gragoudas ES, Seddon JM. Management of choroidal melanomas. Int Ophthalmol Clin. 1986; 26(2):145-58.
    View in: PubMed
    Score: 0.049
  13. Seddon JM, Gragoudas ES, Albert DM, Hsieh CC, Polivogianis L, Friedenberg GR. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol. 1985 Mar 15; 99(3):282-90.
    View in: PubMed
    Score: 0.047
  14. Austin-Seymour M, Munzenrider JE, Goitein M, Gentry R, Gragoudas E, Koehler AM, McNulty P, Osborne E, Ryugo DK, Seddon J, et al. Progress in low-LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas. Radiat Res Suppl. 1985; 8:S219-26.
    View in: PubMed
    Score: 0.046
  15. Fournier GA, Albert DM, Arrigg CA, Cohen AM, Lamping KA, Seddon JM. Resection of solitary metastasis. Approach to palliative treatment of hepatic involvement with choroidal melanoma. Arch Ophthalmol. 1984 Jan; 102(1):80-2.
    View in: PubMed
    Score: 0.043
  16. Lavin PT, Albert DM, Seddon JM. A deficit survival analysis to assess the natural history of uveal melanoma. J Chronic Dis. 1984; 37(6):481-7.
    View in: PubMed
    Score: 0.043
  17. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 1983 Dec; 101(12):1894-9.
    View in: PubMed
    Score: 0.043
  18. Seddon JM, Gragoudas ES, Albert DM. Ciliary body and choroidal melanomas treated by proton beam irradiation. Histopathologic study of eyes. Arch Ophthalmol. 1983 Sep; 101(9):1402-8.
    View in: PubMed
    Score: 0.042
  19. Seddon JM, MacLaughlin DT, Albert DM, Gragoudas ES, Ference M. Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas. Br J Ophthalmol. 1982 Nov; 66(11):695-704.
    View in: PubMed
    Score: 0.040
  20. Kleinerman RA, Schonfeld SJ, Abramson DH, Francis JH, Seddon JM, Morton LM, Tucker MA. Increased Risk of Skin Cancer in 1,851 Long-Term Retinoblastoma Survivors. J Invest Dermatol. 2021 12; 141(12):2849-2857.e3.
    View in: PubMed
    Score: 0.036
  21. Li W, Judge H, Gragoudas ES, Seddon JM, Egan KM. Patterns of tumor initiation in choroidal melanoma. Cancer Res. 2000 Jul 15; 60(14):3757-60.
    View in: PubMed
    Score: 0.034
  22. Gragoudas ES, Lane AM, Regan S, Li W, Judge HE, Munzenrider JE, Seddon JM, Egan KM. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000 Jun; 118(6):773-8.
    View in: PubMed
    Score: 0.033
  23. Egan KM, Walsh SM, Seddon JM, Gragoudas ES. An evaluation of the influence of reproductive factors on the risk of metastases from uveal melanoma. Ophthalmology. 1993 Aug; 100(8):1160-5; discussion 1166.
    View in: PubMed
    Score: 0.021
  24. Ajani UA, Seddon JM, Hsieh CC, Egan KM, Albert DM, Gragoudas ES. Occupation and risk of uveal melanoma. An exploratory study. Cancer. 1992 Dec 15; 70(12):2891-900.
    View in: PubMed
    Score: 0.020
  25. Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol. 1992 Aug; 110(8):1112-8.
    View in: PubMed
    Score: 0.019
  26. Guyer DR, Mukai S, Egan KM, Seddon JM, Walsh SM, Gragoudas ES. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology. 1992 Aug; 99(8):1278-85.
    View in: PubMed
    Score: 0.019
  27. Gragoudas ES, Egan KM, Seddon JM, Walsh SM, Munzenrider JE. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology. 1992 May; 99(5):760-6.
    View in: PubMed
    Score: 0.019
  28. Gragoudas ES, Egan KM, Arrigg PG, Seddon JM, Glynn RJ, Munzenrider JE. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol. 1992 Apr; 110(4):475-9.
    View in: PubMed
    Score: 0.019
  29. Egan KM, Gragoudas ES, Seddon JM, Walsh SM. Smoking and the risk of early metastases from uveal melanoma. Ophthalmology. 1992 Apr; 99(4):537-41.
    View in: PubMed
    Score: 0.019
  30. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991 Mar; 98(3):383-9; discussion 390.
    View in: PubMed
    Score: 0.018
  31. Lischko AM, Seddon JM, Gragoudas ES, Egan KM, Glynn RJ. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology. 1989 Dec; 96(12):1716-21.
    View in: PubMed
    Score: 0.016
  32. Glynn RJ, Seddon JM, Gragoudas ES, Egan KM, Hart LJ. Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma. Ophthalmology. 1989 Oct; 96(10):1566-73.
    View in: PubMed
    Score: 0.016
  33. Munzenrider JE, Verhey LJ, Gragoudas ES, Seddon JM, Urie M, Gentry R, Birnbaum S, Ruotolo DM, Crowell C, McManus P, et al. Conservative treatment of uveal melanoma: local recurrence after proton beam therapy. Int J Radiat Oncol Biol Phys. 1989 Sep; 17(3):493-8.
    View in: PubMed
    Score: 0.016
  34. Egan KM, Gragoudas ES, Seddon JM, Glynn RJ, Munzenreider JE, Goitein M, Verhey L, Urie M, Koehler A. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 1989 Sep; 96(9):1377-82; discussion 1382-3.
    View in: PubMed
    Score: 0.016
  35. Polivogianis L, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Comparison of transillumination and histologic slide measurements of tumor diameter in uveal melanoma. Ophthalmology. 1988 Nov; 95(11):1576-82.
    View in: PubMed
    Score: 0.015
  36. Munzenrider JE, Gragoudas ES, Seddon JM, Sisterson J, McNulty P, Birnbaum S, Johnson K, Austin-Seymour M, Slater J, Goitein MM, et al. Conservative treatment of uveal melanoma: probability of eye retention after proton treatment. Int J Radiat Oncol Biol Phys. 1988 Sep; 15(3):553-8.
    View in: PubMed
    Score: 0.015
  37. Gragoudas ES, Seddon JM, Egan KM, Glynn RJ, Goitein M, Munzenrider J, Verhey L, Urie M, Koehler A. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology. 1988 Jul; 95(7):992-9.
    View in: PubMed
    Score: 0.015
  38. Adams KS, Abramson DH, Ellsworth RM, Haik BG, Bedford M, Packer S, Seddon J, Albert D, Polivogianis L. Cobalt plaque versus enucleation for uveal melanoma: comparison of survival rates. Br J Ophthalmol. 1988 Jul; 72(7):494-7.
    View in: PubMed
    Score: 0.015
  39. Kolodny NH, Gragoudas ES, D'Amico DJ, Seddon JM, Minichiello M, Murphy EJ, Albert DM. Preliminary results on phosphorus-31 nuclear magnetic resonance evaluation of human uveal melanoma in enucleated eyes. Ophthalmology. 1988 May; 95(5):666-73.
    View in: PubMed
    Score: 0.014
  40. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988 Jan-Feb; 32(4):239-51.
    View in: PubMed
    Score: 0.014
  41. Gragoudas ES, Seddon JM, Egan K, Glynn R, Munzenrider J, Austin-Seymour M, Goitein M, Verhey L, Urie M, Koehler A. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology. 1987 Apr; 94(4):349-53.
    View in: PubMed
    Score: 0.013
  42. Gamel J, Seddon J, Polivogianis L, Albert D, Greenberg R. A method for assessing potential bias among cancer patients recorded as "dead of other causes." Application to cases of intraocular melanoma. Cancer. 1986 Jun 01; 57(11):2246-9.
    View in: PubMed
    Score: 0.013
  43. Gragoudas ES, Seddon JM, Egan KM, Polivogianis L, Hsieh CC, Goitein M, Verhey L, Munzenrider J, Austin-Seymour M, Urie M, et al. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmology. 1986 May; 93(5):675-80.
    View in: PubMed
    Score: 0.013
  44. Gamel JW, Greenberg RA, McLean IW, Seddon JM, Albert DM, Naids RE, Folberg R, Donoso LA. A clinically useful method for combining gross and microscopic measurements to select high-risk patients after enucleation for ciliochoroidal melanoma. Cancer. 1986 Apr 01; 57(7):1341-4.
    View in: PubMed
    Score: 0.013
  45. Riedel KG, Svitra PP, Seddon JM, Albert DM, Gragoudas ES, Koehler AM, Coleman DJ, Torpey J, Lizzi FL, Driller J. Proton beam irradiation and hyperthermia. Effects on experimental choroidal melanoma. Arch Ophthalmol. 1985 Dec; 103(12):1862-9.
    View in: PubMed
    Score: 0.012
  46. Fournier GA, Saulenas AM, Seddon JM, Goitein M, Albert DM, Polivogianis L, Gragoudas E. The effects of pre-enucleation irradiation on the development of metastases from intraocular Greene melanoma in hamsters. Am J Ophthalmol. 1985 Nov 15; 100(5):669-77.
    View in: PubMed
    Score: 0.012
  47. Weinhaus RS, Seddon JM, Albert DM, Gragoudas ES, Robinson N. Prognostic factor study of survival after enucleation for juxtapapillary melanomas. Arch Ophthalmol. 1985 Nov; 103(11):1673-7.
    View in: PubMed
    Score: 0.012
  48. Pascal SG, Saulenas AM, Fournier GA, Seddon JM, Hatfield RM, Albert DM. An investigation into the association between liver damage and metastatic uveal melanoma. Am J Ophthalmol. 1985 Sep 15; 100(3):448-53.
    View in: PubMed
    Score: 0.012
  49. Gamel JW, McLean I, Greenberg RA, Naids RM, Folberg R, Donoso LA, Seddon JM, Albert DM. Objective assessment of the malignant potential of intraocular melanomas with standard microslides stained with hematoxylin-eosin. Hum Pathol. 1985 Jul; 16(7):689-92.
    View in: PubMed
    Score: 0.012
  50. Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005 Apr 01; 23(10):2272-9.
    View in: PubMed
    Score: 0.012
  51. Gragoudas ES, Seddon J, Goitein M, Verhey L, Munzenrider J, Urie M, Suit HD, Blitzer P, Koehler A. Current results of proton beam irradiation of uveal melanomas. Ophthalmology. 1985 Feb; 92(2):284-91.
    View in: PubMed
    Score: 0.012
  52. Gragoudas ES, Goitein M, Seddon J, Verhey L, Munzenrider J, Urie M, Suit HD, Blitzer P, Johnson KN, Koehler A. Preliminary results of proton beam irradiation of macular and paramacular melanomas. Br J Ophthalmol. 1984 Jul; 68(7):479-85.
    View in: PubMed
    Score: 0.011
  53. terPenning BJ, Cheng HM, Barnett P, Seddon J, Sang D, Latina M, Aguayo J, Gonz?lez RG, Brady TJ. MR imaging of enucleated human eyes at 1.4 tesla. J Comput Assist Tomogr. 1986 Jul-Aug; 10(4):551-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.